Mostrando 6 resultados de: 6
Origen
scopus(6)
Clinical pbkp_redictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort
ArticleAbstract: Objectives: To identify baseline pbkp_redictors of remission and low disease activity (LDA) in earlyPalabras claves:Early RA outcomes, Early RA remission, Early RA response pbkp_redictors, Latin America early RAAutores:Achurra-Castillo A.F., Alarcón G.S., Andrade-Ortega L., Appenzeller S., Ballesteros F., Barile-Fabris L.A., Bianchi W.A., Caballero-Uribe C.V., Cardiel M.H., Castelar-Pinheiro G.d.R., Claudio M. Galarza-Maldonado, Da Silveira I.G., de Freitas Zerbini C.A., Esquivel-Valerio J.A., Esteva-Spinetti M.H., Gamboa-Cárdenas R.V., García de la Torre I., Guibert-Toledano M., Loreto M., Monge P., Montufar R.A., Palezuelos F.I., Pisoni C.N., Pons-Estel B.A., Radominski S.C., Rios C., Rojas-Villarraga A., Sacnun M.P., Saurit V., Soriano E.R., Teijeiro R., Ugarte-Gil M.F., Vazquez-Mellado J.Fuentes:scopusCorrection to: Clinical pbkp_redictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort (Clinical Rheumatology, (2019), 38, 10, (2737-2746), 10.1007/s10067-019-04618-x)
OtherAbstract: The original version of this article, unfortunately, contained an error. The first and family name oPalabras claves:Autores:Achurra-Castillo A.F., Alarcón G.S., Andrade-Ortega L., Appenzeller S., Ballesteros F., Barile-Fabris L.A., Bianchi W.A., Caballero-Uribe C.V., Cardiel M.H., Castelar-Pinheiro G.d.R., Claudio M. Galarza-Maldonado, Da Silveira I.G., de Freitas Zerbini C.A., Esquivel-Valerio J.A., Esteva-Spinetti M.H., Gamboa-Cárdenas R.V., García de la Torre I., Guibert-Toledano M., Massardo L., Monge P., Montufar R.A., Palezuelos F.I., Pisoni C.N., Pons-Estel B.A., Radominski S.C., Rios C., Rojas-Villarraga A., Sacnun M.P., Saurit V., Soriano E.R., Teijeiro R., Ugarte-Gil M.F., Vazquez-Mellado J.Fuentes:scopusCorrection to: PANLAR consensus statement on biosimilars (Clinical Rheumatology, (2019), 38, 5, (1485-1496), 10.1007/s10067-019-04496-3)
OtherAbstract: The two co-authors of the mentioned above article were incorrect. The correct are authors should havPalabras claves:Autores:Avila-Pedretti G., Azevedo V.F., Babini A.M., Beltrán P.A., Benavides J.A., Caballero-Uribe C.V., Cachafeiro-Vilar A., Cifuentes-Alvarado M., Claudio M. Galarza-Maldonado, Cohen S.B., Díaz P.E., Díaz-Coto J.F., Encalada C., Firedman D.X.X., Garro B., Guibert-Toledano M., Kay J., Kowalski S.C., Lopez M.E.L., Mysler E., Ortega A.P., Pineda-Villaseñor C., Rodriguez V.J.K., Russell A.S., Santos-Moreno P., Sariego I.A.G., Soriano E.R., Terán I.S., Vargas A., Vásquez G., Xavier R.M.Fuentes:scopusFirst Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
ArticleAbstract: Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease, represents a sigPalabras claves:lupus nephritis, systemic lupus erythematosus, TreatmentAutores:Acevedo-Vásquez E.M., Acosta Colman M.I., Alarcón G.S., Alba Moreyra P.B., Alvarellos A.J., Amezcua-Guerra L.M., Amigo M.C., Appenzeller S., Aquino A.M., Arturi V., Babini A.M., Barile-Fabris L.A., Berbotto G.A., Betancur G.V., Bonfá E.S.D.D.O., Borba E.F., Brenol J.C.T., Burgos P.I., Cairoli E., Cardiel M.H., Cardoso Linhares F.A., Catoggio L.J., Cavalcanti A., Cavalcanti F.S., Chacón-DÍaz R., Cieza J., Claudio M. Galarza-Maldonado, Collado M.V., Conti S.M., Costallat L.T.L., Criniti J.M., Da Silva N.A., Danza A., Dos Reis Neto E.T., Drenkard C., Duarte M., Eraso Garnica R.M., Espada G., Fragoso-Loyo H.E., Fuentes-Silva Y.J., Gamboa-Cárdenas R.V., García de la Torre I., García M.A., García Valladares I., Gerling C., Gervasoni V.L., Gobbi C.A., Gómez-Martín D., Gómez-Puerta J.A., González Naranjo L.A., González-Bello Y.C., Gordon S., Guibert-Toledano M., Haye Salinas M.J., Herrera Uribe S., Iglesias Gamarra A.J., Izcovich A., Levy R.A., Llanos C., Massardo L., Molina J.F., Montandon De Oliveira E Silva A.C., Monticielo O.A., Montúfar Guardado R.A., Mora-Trujillo C.S., Muñoz-Louis R., Neira O., Orozco M.C., Pera M.A., Pineda-Villaseñor C., Pons-Estel B.A., Pons-Estel G.J., Popoff F., Portela Hernández M., Quintana R.M., Retamozo S., Reyes G.L., Robaina Sevrini R., Rosario V., Sarano J., Sato E.I., Sattler M.E., Saurit V., Savio V., Scherbarth H.R., Scolnik M., Seguro L.P.C., Silva C.A., Silveira L.H., Soriano E.R., Ugarte-Gil M.F., Ugolini-Lopes M.R., Vargas Peña A., Vásquez G., Xavier R.M.Fuentes:scopusPANLAR consensus statement on biosimilars
ArticleAbstract: Introduction: Biologics have improved the treatment of rheumatic diseases, resulting in better outcoPalabras claves:Biosimilars, consensus, PANLAR, Rheumatic diseasesAutores:Avila-Pedretti G., Azevedo V.F., Babini A.M., Benavides J.A., Caballero-Uribe C.V., Cachafeiro-Vilar A., Cifuentes-Alvarado M., Claudio M. Galarza-Maldonado, Cohen S.B., Díaz P.E., Encalada C., Firedman D.X.X., Garro B., Guibert-Toledano M., Kay J., Kowalski S.C., Lopez M.E.L., Mysler E., Ortega A.P., Pineda-Villaseñor C., Roa P.A.B., Rodriguez V.J.K., Russell A.S., Santos-Moreno P., Sariego I.A.G., Soriano E.R., Soto L.D., Terán I.S., Vargas A., Vásquez G., Xavier R.M.Fuentes:scopusUse of rituximab for the treatment of rheumatoid arthritis: The Latin American context
ArticleAbstract:Palabras claves:Anti-CD20 antibody, Biologic therapy, Latin America, Rheumatoid Arthritis, rituximab, Treatment guidelinesAutores:Achurra-Castillo A.F., Alarcón G.S., Barile-Fabris L.A., Caballero-Uribe C.V., Cardiel M.H., Chávez-Corrales J.E., Claudio M. Galarza-Maldonado, Díaz-Coto J.F., Esteva-Spinetti M.H., Guibert-Toledano M., Keiserman M.W., Lomonte A.V., Massardo L., Mota L.M.H., Palazuelos I.F., Pineda-Villaseñor C., Pons-Estel B.A., Soriano E.R.Fuentes:scopus